Previous 10 | Next 10 |
The steep decline in INMD has been a great opportunity for investors with a longer time horizon to increase their potential returns by buying the dip. The current disconnect between the business and the stock creates a great buying opportunity for risk tolerant investors. The US, ...
InMode continues its growth in the US and internationally. Celebrities have adopted the company’s products. Clinical trials for non-elective surgical equipment shows promise. For further details see: Is InMode Ready To Explode?
Gainers: Iovance Biotherapeutics IOVA +12%. Katapult Holdings KPLT +12%. Gladstone Land Corporation (NASDAQ:LAND) +5%. INMODE (NASDAQ:INMD) +4%. Chimerix CMRX +3%. Losers: CarParts.com PRTS -14%. Dada Nexus Limited (NASDAQ:DADA) -13%. Incannex Healthcare Limited ...
InMode (NASDAQ:INMD) has announced a share repurchase program to buyback up to 1M ordinary shares on the open market or otherwise. The share repurchases, if any, will be funded with available cash. INMD is down 3.47% pre-market and 40.78% YTD For further details see: ...
InMode to Participate in Investor Conferences in March PR Newswire YOKNEAM, Israel , March 2, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that management will participate in th...
We have 14 top ideas from Marketplace contributors to share with you. As usual, there's a wide range from energy to tech and value. And a big congratulations to Laurentian Research who had 2021's top performer with near 400% returns. For further details see: 2022 Marketp...
As a medical equipment company focused on developing innovative devices to perform aesthetic procedures, InMode (NASDAQ: INMD) has a lot to offer investors. With its snappy revenue growth, robust profitability, and consistent investment in research and development, there are man...
Arenberg Capital reiterates hold rating taking into account detailed FY21 data. We update our DCF-based price target to $42.03. Despite fair valuation, macro headwinds are set to impact the overall market sentiment negatively. For further details see: InMode: Reiterate H...
Image source: The Motley Fool. InMode Ltd. (NASDAQ: INMD) Q4 2021 Earnings Call Feb 10, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: InMode Ltd. (INMD) Q4 2021 Earnings Call Transcript
InMode Ltd. (INMD) Q4 2021 Earnings Conference Call February 10, 2022, 08:30 AM ET Company Participants Miri Segal - MS-IR Moshe Mizrahy - Chairman & CEO Shakil Lakhani - President, North America Yair Malca - CFO Spero Theodorou - CMO Conference Call Participants Matt Taylor - UBS Kyle Ro...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 06:00:08 ET Matthew Taylor from Jefferies issued a price target of $19.00 for INMD on 2024-07-23 05:00:00. The adjusted price target was set to $19.00. At the time of the announcement, INMD was trading at $17.75. The overall price target consensus is at $34.50...
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling PR Newswire IRVINE, Calif. , July 17, 2024 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technolog...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 5.6% to $127.4 on volume of 368,729,821 shares Maxeon Solar Technologies Ltd. (MAXN) rose 14.2% to $0.2407 on volume of 294,399,898 shares Kazia Therapeutics Limited (KZIA) rose 85.6% to $1.24 on volume ...